Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Bill.com Holdings Inc.

Start price
Target price
Perf. (%)
€152.00
08.02.21
-
08.02.22
-20.39%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
FXX 
08.02.21 40%
sell
Qualtrics International Inc.

Start price
Target price
Perf. (%)
€37.52
16.02.21
€30.00
-21.35%
24.03.21

Low dividend yield expected
Few uniques
Below average Marketposition
Probably not worthwhile Investment
Snowman 
16.02.21 60%
buy
Razer Inc.

Start price
Target price
Perf. (%)
€0.35
16.02.21
€0.60
-28.13%
24.03.21

Revenue growth >5% per year expected
Very capable Management
Very good company culture
Leading role in innovation
sailamac 
16.02.21 10%
sell
Bilibili Inc.

Start price
Target price
Perf. (%)
€86.50
10.03.21
-
10.03.22
7.51%
20.03.21

DrMabuse 
10.03.21 0%
buy
STS Group AG

Start price
Target price
Perf. (%)
€6.90
15.03.21
€8.00
8.41%
18.03.21

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Traumtanz 
15.03.21 80%
buy
NAGA Group

Start price
Target price
Perf. (%)
€6.15
06.02.21
-
06.02.22
14.63%
11.03.21

Could be very worthwhile Investment >20% year
Savour 
06.02.21 20%
buy
Slack Technologies Inc.

Start price
Target price
Perf. (%)
€26.80
18.05.20
-
04.11.21
28.73%
11.03.21

Could be very worthwhile Investment >20% year
Savour 
18.05.20 50%
sell
Wirecard AG ADR

Start price
Target price
Perf. (%)
€0.51
05.09.20
-
04.11.21
-67.72%
11.03.21

Probably not worthwhile Investment
Savour 
05.09.20 50%
buy
Yunhong Cti Ltd.

Start price
Target price
Perf. (%)
€2.74
23.02.21
€4.00
23.02.22
-32.12%
06.03.21

Could be worthwhile Investment >10% per year
Good culture
Fair valuation
Below average Management
me8 
23.02.21 0%
sell
Ocugen Inc.

Start price
Target price
Perf. (%)
€6.88
23.02.21
-
23.02.22
34.59%
01.03.21

Could be worthwhile Investment >10% per year
Amped 
23.02.21 0%
sell
thyssenkrupp AG ADR

Start price
Target price
Perf. (%)
€6.15
05.12.20
-
05.12.21
85.37%
27.02.21

Top 10 in its market
Probably not worthwhile Investment
Significant cyclical dependencies
Business model of the past or high risk
Commando 
05.12.20 50%
buy
Niu Technologies

Start price
Target price
Perf. (%)
€35.50
19.02.21
€38.00
-13.52%
23.02.21

Risky Investment
phonebroker 
19.02.21 50%
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€8.90
18.02.21
€12.00
16.05.21
-22.70%
23.02.21

Could be worthwhile Investment >10% per year
Amped 
18.02.21 70%
sell
Nikola Corp.

Start price
Target price
Perf. (%)
€19.85
08.02.21
-
08.02.22
-9.17%
22.02.21

Risky Investment
Gilbert 
08.02.21 50%
sell
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.02
17.02.21
€12.00
16.05.21
-1.33%
18.02.21

Could be worthwhile Investment >10% per year
Amped 
17.02.21 70%
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.40
16.02.21
€12.00
16.05.21
-4.04%
17.02.21

Could be worthwhile Investment >10% per year
Amped 
16.02.21 70%
sell
Everfuel A/S

Start price
Target price
Perf. (%)
€6.20
28.11.20
-
28.11.21
83.06%
16.02.21

Business model of the past or high risk
Below average Marketposition
Risky Investment
Significant cyclical dependencies
tinelchen 
28.11.20 20%
sell
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.78
16.02.21
€5.00
16.05.21
-3.89%
16.02.21

Could be worthwhile Investment >10% per year
Amped 
16.02.21 70%
buy
Futu Holdings Ltd.

Start price
Target price
Perf. (%)
€36.20
13.11.20
€109.00
13.05.21
234.25%
12.02.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
Higher risks for its business
RudolfL 
13.11.20 50%
sell
Ocugen Inc.

Start price
Target price
Perf. (%)
€11.35
08.02.21
€8.00
08.02.22
-30.04%
11.02.21

Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
me8 
08.02.21 0%
sell
Xpel Inc.

Start price
Target price
Perf. (%)
€44.00
25.01.21
-
25.01.22
7.27%
09.02.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
PlusUltra 
25.01.21 60%
buy
Synlogic Inc.

Start price
Target price
Perf. (%)
€3.00
14.12.20
€3.00
14.12.21
0.00%
29.01.21

Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
me8 
14.12.20 50%
buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
me8 
14.12.20 50%
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
me8 
14.12.20 50%
buy
Aileron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.50
11.01.21
-
11.01.22
-6.67%
29.01.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Growths slower than the competition
me8 
11.01.21 0%